3B Blackbio Dx Limited (NSE:3BBLACKBIO)
India · Delayed Price · Currency is INR 1,419.90
-23.40 (-1.62%)
At close: Sep 11, 2026
3B Blackbio Dx Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 599.3 | 476.91 | 321.01 | 259.37 | 322 |
Depreciation & Amortization | 51.26 | 10.86 | 10.57 | 8.63 | 6.72 |
Loss (Gain) From Sale of Assets | - | - | -0.1 | - | - |
Loss (Gain) From Sale of Investments | -29.74 | -60.59 | -57.86 | -26.21 | - |
Other Operating Activities | 11.22 | 16.31 | 11.78 | 6.3 | 5.69 |
Change in Accounts Receivable | -186.83 | -17.95 | -97.35 | -17.73 | 332.14 |
Change in Inventory | -96.36 | -3.15 | -1.19 | -6.1 | -25.6 |
Change in Accounts Payable | 175.91 | 11.17 | 82.66 | -21.42 | -267.68 |
Operating Cash Flow | 524.76 | 433.57 | 269.51 | 202.84 | 373.26 |
Operating Cash Flow Growth | 21.03% | 60.87% | 32.87% | -45.66% | -61.72% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -255.1 | -9.04 | -5.08 | -20.25 | -22.63 |
Cash Acquisitions | 76.58 | - | - | - | - |
Investment in Securities | -57.15 | -329.42 | -198.11 | 144.61 | -338.26 |
Other Investing Activities | -0.26 | -0 | - | 22.96 | 76.45 |
Investing Cash Flow | -235.93 | -338.46 | -203.19 | 147.33 | -284.44 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 3.36 | - | - | 1.31 | 7.04 |
Long-Term Debt Repaid | - | -0.63 | -11.11 | -5.75 | -1.78 |
Total Debt Repaid | - | -0.63 | -11.11 | -5.75 | -1.78 |
Net Debt Issued (Repaid) | 3.36 | -0.63 | -11.11 | -4.44 | 5.26 |
Issuance of Common Stock | - | - | 0.02 | - | 0 |
Common Dividends Paid | -34.23 | -25.67 | -21.93 | -44.38 | -154.63 |
Other Financing Activities | 25.63 | -5.9 | -3.24 | -1.25 | -1.34 |
Financing Cash Flow | -5.24 | -32.19 | -36.25 | -50.07 | -150.7 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 34.28 | 3.94 | -0.65 | 3.03 | - |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - |
Net Cash Flow | 317.87 | 66.85 | 29.42 | 303.14 | -61.88 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 269.66 | 424.53 | 264.43 | 182.6 | 350.63 |
Free Cash Flow Growth | -36.48% | 60.54% | 44.82% | -47.92% | -63.42% |
Free Cash Flow Margin | 19.00% | 44.01% | 35.53% | 29.42% | 40.05% |
Free Cash Flow Per Share | 31.47 | 49.55 | 30.86 | 21.32 | 46.80 |
Levered Free Cash Flow | 64.88 | 784.41 | 236.48 | -409.19 | 293.09 |
Unlevered Free Cash Flow | 66.36 | 785.09 | 237.26 | -407.95 | 293.75 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 2.37 | 1.09 | 1.25 | 1.98 | 1.06 |
Cash Income Tax Paid | 161.55 | 147.85 | 108.41 | 89.41 | 105.61 |
Change in Working Capital | -107.28 | -9.92 | -15.89 | -45.25 | 38.86 |